Literature DB >> 19287841

Phenotypic detection and occurrence of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli at a tertiary hospital in Trinidad & Tobago.

Patrick E Akpaka1, William H Swanston.   

Abstract

The incidence and distribution of ESBL producing microorganisms such as E. coli and K. pneumoniae have been demonstrated and varies in different health care facilities and as well as other countries This study was carried out to determine the frequency of occurrence and the antimicrobial susceptibility pattern of ESBL producing E. coli and K. pneumoniae species from clinical isolates at a tertiary hospital in Trinidad & Tobago. Standard microbiological procedures and automated MicroScan System was used to identify, screen for putative ESBL production and determine antimicrobial susceptibility of 1,118 clinical isolates of Enterobacteriaceae species at the microbiology laboratory of the Eric Williams Medical Science Complex, Trinidad & Tobago over a 36 months period. All ESBL producing isolates flagged by the automated system were further confirmed by E-test method. The E-test confirmed a 15.2% ESBL rate among the K. pneumoniae isolates and 9.3% among the E. coli isolates. There was also a 1.8% rate of ESBL production in K. pneumoniae and 0.2% in E. coli isolates from specimens received from community health facilities into the laboratory. Isolates recovered from the intensive care unit of the hospital had 2.1% E. coli and 8.2% K. pneumoniae ESBL producers. Although all ESBL positive isolates were completely susceptible to imipenem and meropenem; and all positive K. pneumoniae isolates were susceptible to amikacin, there was a low susceptibility of ESBL positive E. coli to the aminoglycosides. However, susceptibility of these ESBL producing isolates to the fluoroquinolones varied. There is a high rate of ESBL production among isolates of E. coli and K. pneumoniae at this hospital that is linked to the extensive inappropriate use of third generation cephalosporins in the country. Further molecular studies are needed to characterize the types of these ESBL prevailing in the country.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19287841     DOI: 10.1590/s1413-86702008000600014

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  5 in total

1.  Characterization of Beta-Lactam Resistance Genes and Virulence Factors Associated with Multidrug-Resistant Klebsiella pneumoniae Isolated from Patients at Major Hospitals in Trinidad, West Indies.

Authors:  Aarti Pustam; Jayaraj Jayaraman; Adesh Ramsubhag
Journal:  Curr Microbiol       Date:  2022-08-03       Impact factor: 2.343

2.  ESBL Production Among E. coli and Klebsiella spp. Causing Urinary Tract Infection: A Hospital Based Study.

Authors:  Pooja Shakya; Dhiraj Shrestha; Elina Maharjan; Vijay K Sharma; Rabin Paudyal
Journal:  Open Microbiol J       Date:  2017-04-28

3.  Detection of a CTX-M group 2 beta-lactamase gene in a Klebsiella pneumoniae isolate from a tertiary care hospital, Trinidad and Tobago.

Authors:  Paul Cheddie; Francis Dziva; Patrick Eberechi Akpaka
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-05-08       Impact factor: 3.944

4.  A national survey of the knowledge, attitudes and prescribing practices of doctors regarding antibiotic resistance in a Caribbean country.

Authors:  Alison Nicholson; Ingrid Tennant; Livingston White; Camille-Ann Thoms-Rodriguez; Loraine Cook; Stephen Johnson; Tamara Thompson; Jasper Barnett; Lundie Richards
Journal:  Antimicrob Resist Infect Control       Date:  2018-02-15       Impact factor: 4.887

5.  Caribbean multi-centre study of Klebsiella pneumoniae: whole-genome sequencing, antimicrobial resistance and virulence factors.

Authors:  Eva Heinz; Richard Brindle; Andrina Morgan-McCalla; Keisha Peters; Nicholas R Thomson
Journal:  Microb Genom       Date:  2019-04-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.